News | March 31, 2026
Roche launches groundbreaking multiplex test to boost blood safety
The new assay consolidates screening for four major viral threats into a single workflow
The new assay consolidates screening for four major viral threats into a single workflow
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The decision is based on the phase 3 DESTINY-Breast11 trial
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The presentations underscore the company’s deep expertise in dermatology and immunology
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
High-level results from the Phase III OBERON and TITANIA trials revealed that the first-in-class monoclonal antibody reduced the annual rate of moderate-to-severe COPD exacerbations compared with placebo
Subscribe To Our Newsletter & Stay Updated
